Pantothenate Kinase-Associated Neurodegeneration (PKAN) and PLA2G6-Associated Neurodegeneration (PLAN): Review of Two Major Neurodegeneration with Brain Iron Accumulation (NBIA) Phenotypes

被引:70
|
作者
Kurian, Manju A. [1 ,2 ]
Hayflick, Susan J. [3 ,4 ,5 ]
机构
[1] UCL Inst Child Hlth, Neurosci Unit, London, England
[2] Great Ormond St Hosp Sick Children, Dept Neurol, London, England
[3] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA
[5] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
来源
基金
英国惠康基金;
关键词
INFANTILE NEUROAXONAL DYSTROPHY; HALLERVORDEN-SPATZ-SYNDROME; PALLIDAL STIMULATION; PHOSPHOLIPASE A(2); REPETITIVE SPEECH; PLA2G6; MUTATION; PANK2; MUTATIONS; TIGER SIGN; DYSTONIA; SPECTRUM;
D O I
10.1016/B978-0-12-410502-7.00003-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurodegeneration with brain iron accumulation (NBIA) comprises a heterogeneous group of disorders characterized by the presence of radiologically discernible high brain iron, particularly within the basal ganglia. A number of childhood NBIA syndromes are described, of which two of the major subtypes are pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN). PKAN and PLAN are autosomal recessive NBIA disorders due to mutations in PANK2 and PLA2G6, respectively. Presentation is usually in childhood, with features of neurological regression and motor dysfunction. In both PKAN and PLAN, a number of classical and atypical phenotypes are reported. In this chapter, we describe the clinical, radiological, and genetic features of these two disorders and also discuss the pathophysiological mechanisms postulated to play a role in disease pathogenesis.
引用
收藏
页码:49 / 71
页数:23
相关论文
共 50 条
  • [21] Pantothenate Kinase-Associated Neurodegeneration (PKAN) With Concomitant Blepharospasm: Unveiling a Clinical Enigma
    Reddy, Venkat
    Saboo, Keyur
    Reddy, Kavyanjali
    Kumar, Sunil
    Acharya, Sourya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [22] Deep Brain Stimulation (DBS) in Pantothenate Kinase-Associated Neurodegeneration (PKAN): An Experience in a Thai Patient
    Termsarasab, P.
    Boonkongchuen, P.
    Pulkes, T.
    Trachoo, O.
    Boongird, A.
    MOVEMENT DISORDERS, 2019, 34 : S880 - S880
  • [23] A CASE OF LATE ONSET PLA2G6-ASSOCIATED NEURODEGENERATION (PLAN) WITH PARKINSONISM
    Pak, T.
    Yarenci, E.
    Karadag, Y. Sucullu
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [24] Vitamin E prevents lipid peroxidation and iron accumulation in PLA2G6-Associated Neurodegeneration
    Villalon-Garcia, Irene
    Alvarez-Cordoba, Monica
    Povea-Cabello, Suleva
    Talaveron-Rey, Marta
    Villanueva-Paz, Marina
    Luzon-Hidalgo, Raquel
    Suarez-Rivero, Juan M.
    Suarez-Carrillo, Alejandra
    Munuera-Cabeza, Manuel
    Salas, Joaquin J.
    Falcon-Moya, Rafael
    Rodriguez-Moreno, Antonio
    Armengol, Jose A.
    Sanchez-Alcazar, Jose A.
    NEUROBIOLOGY OF DISEASE, 2022, 165
  • [25] PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION TREATED WITH DEEP BRAIN STIMULATION
    Rosas, M. J.
    Gago, M. F.
    Brandao, E.
    Oliveira, A.
    Linhares, P.
    Ayres-Basto, M.
    Volkmann, J.
    Vaz, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 520 - 520
  • [26] Novel Therapeutic Strategies in NBIA: A Gene Therapy Approach for PLA2G6-Associated Neurodegeneration
    Cuka, Sammie
    Ng, Joane
    Seino, Ken
    Hughes, Michael
    Massaro, Giulia
    Waddington, Simon
    Kurian, Manju
    Rahim, Ahad
    HUMAN GENE THERAPY, 2017, 28 (08) : A35 - A35
  • [27] Atypical pantothenate kinase-associated neurodegeneration with variable phenotypes in an Egyptian family
    Shalash, Ali S.
    Roesler, Thomas W.
    Abdelrahman, Ibrahim Y.
    Abulmakarem, Hatem S.
    Muller, Stefanie H.
    Hopfner, Franziska
    Kuhlenbaeumer, Gregor
    Hoeglinger, Gunter U.
    Salama, Mohamed
    HELIYON, 2021, 7 (07)
  • [28] PANK2 gene mutations in Italian patients with pantothenate kinase-associated neurodegeneration (PKAN)
    Giovonetti, A.
    Zorzi, G.
    Borzaghi, C.
    Zibordi, F.
    Ghezzi, D.
    Chiapparini, L.
    Nardocci, N.
    Garavaglia, B.
    MOVEMENT DISORDERS, 2008, 23 (01) : S42 - S42
  • [29] Temporal Emergence of Symptoms and Functional Impairments in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)
    Greblikas, F.
    Jinnah, H. A.
    Klopstock, T.
    Videnovic, A.
    Burns, C.
    MOVEMENT DISORDERS, 2019, 34 : S210 - S210
  • [30] Neurodegeneration with brain iron accumulation: PLA2G6-associated dystonia-parkinsonism: clinical and animal studies
    Minkley, M.
    Jackson, A.
    Smith, D.
    Borchers, C.
    Vichinsky, E.
    Nashmi, R.
    Walter, P. B.
    MacLeod, P. M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 402 - 402